OOIR: Observatory of International Research

Papers

(The H4-Index of Chinese Medicine is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Tea and tea drinking: China’s outstanding contributions to the mankind	120
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities	65
Traditional application and modern pharmacological research of Eucommia ulmoides Oliv.	61
Propolis: An update on its chemistry and pharmacological applications	60
Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ1-42-induced Alzheimer’s disease mice and glutamate-injured HT22 cells	59
Neurobiological effects of gallic acid: current perspectives	59
Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma	59
Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo	55
Pharmacological activities and mechanisms of action of Pogostemon cablin Benth: a review	55
Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction	46
Plant metabolomics: a new strategy and tool for quality evaluation of Chinese medicinal materials	44
The mechanism of electroacupuncture for depression on basic research: a systematic review	40
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives	40
Advances in the study of emodin: an update on pharmacological properties and mechanistic basis	40
Microwave technology: a novel approach to the transformation of natural metabolites	38
Natural drug sources for respiratory diseases from Fritillaria: chemical and biological analyses	38
The toxicology and detoxification of Aconitum: traditional and modern views	38
Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review	37
Anemoside B4 ameliorates TNBS-induced colitis through S100A9/MAPK/NF-κB signaling pathway	37
Quinic acid: a potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa	37
Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity	36
Acupuncture for cancer pain: an evidence-based clinical practice guideline	34
Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury	32
Cucurbitacin B inhibits TGF-β1-induced epithelial–mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways	32
Oral colon-targeting core–shell microparticles loading curcumin for enhanced ulcerative colitis alleviating efficacy	32

Plant super-barcode: a case study on genome-based identification for closely related species of Fritillaria	31
Zoology, chemical composition, pharmacology, quality control and future perspective of Musk (Moschus): a review	31
Chaihu-Shugan-San (Shihosogansan) alleviates restraint stress-generated anxiety and depression in mice by regulating NF-κB-mediated BDNF expression through the modulation of gut microbiota	31
Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs	29
Combination of pseudoephedrine and emodin ameliorates LPS-induced acute lung injury by regulating macrophage M1/M2 polarization through the VIP/cAMP/PKA pathway	29